Drug
Eplerenone
Eplerenone: highest development phase Phase 2/3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Eplerenone NCT01708798 | Phase 2/3 | Breast Cancer |
Latest
No recent events.
Follow Eplerenone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.